| Literature DB >> 28372294 |
Damien Offner1,2,3, Quentin Wagner1,2, Ysia Idoux-Gillet1,2, Hervé Gegout2, Arielle Ferrandon1,2, Pascale Schwinté1,2, Anne-Marie Musset2,3, Nadia Benkirane-Jessel1,2, Laetitia Keller1,2.
Abstract
The time needed to obtain functional regenerated bone tissue depends on the existence of a reliable vascular support. Current techniques used in clinic, for example after tooth extraction, do not allow regaining or preserving the same bone volume. Our aim is to develop a cellularized active implant of the third generation, equipped with human mesenchymal stem cells to improve the quality of implant vascularization. We seeded a commercialized collagen implant with human mesenchymal stem cells (hMSCs) and then with human umbilical vein endothelial cells (HUVECs). We analyzed the biocompatibility and the behavior of endothelial cells with this implant. We observed a biocompatibility of the active implant, and a re-organization of endothelial cells into clustered networks. This work shows the possibility to develop an implant of the third generation supporting vascularization, improving the medical care of patients.Entities:
Keywords: Collagen implant; endothelial cells; mesenchymal stem cells; vascularization
Mesh:
Substances:
Year: 2017 PMID: 28372294 DOI: 10.3233/BME-171640
Source DB: PubMed Journal: Biomed Mater Eng ISSN: 0959-2989 Impact factor: 1.300